Cambridge Cancer Genomics careers
Cambridge Cancer Genomics is using blood tests to guide smarter cancer therapy. Currently, cancer patients have to wait up to 6 months to know whether their chemotherapy is working. In the interim, patients suffer the side effects of such treatments. Using simple blood draws, CCG shortens the time required to know whether treatment is working, buying the clinician more time to alter treatment and reduce unnecessary side effects. In addition, we can identify relapse an average of 7 months earlier than standard practice. Over time, CCG will be able to better predict the best therapeutic strategy for cancer patients before they even begin treatment.
Cambridge Cancer Genomics hasn't added any jobs yet
Get notified when Cambridge Cancer Genomics posts new jobs.
Harry Clifford
Chief Scientific Officer at Cambridge Cancer Genomics, leading development of AI tech, cloud architecture and tumor analysis pipelines.
Evaline Tsai
Founder @Cambridge Cancer Genomics • Studied @Princeton University and @University of Cambridge
Omeros • Seattle • $220k – $240k • 3 days ago
Raspberry Pi Foundation • California • $100k – $130k • 7 days ago
Ptc Therapeutics • United States • $119k – $145k • 2 weeks ago
Eli Lilly • Indianapolis • $69k – $165k • 3 weeks ago
Sanofi Aventis • Cambridge • 3 weeks ago
